Balanced IV Fluids for Kids with Acute Gastroenteritis
Official title: Comparison of Early Biochemical and Clinical Outcomes of Balanced Versus Unbalanced Isotonic Crystalloid in Children Aged 6 Months to 5 Years Who Require Intravenous Rehydration for Acute Gastroenteritis: A Single-Center Prospective Observational Cohort Study
Run by Aydin Adnan Menderes University · NCT07610382 · Data updated 2026-11-12
This study compares balanced crystalloids versus normal saline for IV hydration in young children with acute gastroenteritis to see if it improves acid–base status and clinical outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Months to 5 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Aydin Adnan Menderes University Academic / other |
| Locations | 1 site (Aydin) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | January 2027 |
| Study ends | March 2027 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07610382 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children 6 months to 5 years with acute gastroenteritis requiring IV rehydration and without major chronic illnesses or exclusion criteria.
✕Probably not a fit
Children with complex chronic diseases or severe dehydration due to conditions not related to saline composition may not experience additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study prospectively follows children aged 6 months to 5 years with acute gastroenteritis who require IV fluids. It compares early biochemical and clinical outcomes between those treated with balanced crystalloids (Isolyte-S) and those given normal saline, focusing on metabolic acidosis and bicarbonate levels. The protocol emphasizes physician-initiated fluid orders and real-world practice without research-driven assignments. The rationale is that balanced crystalloids may better correct acidosis due to lower chloride load and bicarbonate precursors. Prior evidence suggests potential benefits but with uncertain certainty, warranting additional observational data in this population.
Why it matters
Potential benefit: If balanced crystalloids prove beneficial, children may experience faster correction of acidosis and improved clinical recovery.
How similar studies have gone: Previous trials and a Cochrane review suggest potential biochemical and clinical advantages with balanced crystalloids, but evidence remains uncertain and higher-quality data are needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 6 months to 5 years (60 months) inclusive * Clinical diagnosis of acute gastroenteritis: acute diarrhoea (3 or more loose stools per 24 hours) with or without vomiting; symptom duration 7 days or less * Clinician-initiated indication for intravenous rehydration * IV fluid order placed and treatment initiated independently by the treating physician, without research team influence Exclusion Criteria: * Chronic systemic disease (congenital heart disease, chronic kidney disease, chronic lung disease, inborn errors of metabolism, primary immunodeficiency) * Hypernatraemic dehydration (serum sodium \>= 150 mEq/L at baseline) * Diabetic ketoacidosis, primary metabolic crisis, or suspected surgical abdomen * Bloody diarrhoea or suspected invasive enteric infection requiring alternative management algorithm * Hypoglycaemia (blood glucose \< 60 mg/dL) at presentation * Symptom duration exceeding 7 days * Receipt of 20 mL/kg or more of IV fluid in the 24 hours preceding enrolment
Where it's running
-
Aydin Adnan Menderes University Hospital, Department of Pediatric Emergency Care
Aydin, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Aykut Çağlar, Professor
- Email: aykutcaglar@gmail.com
- Phone: +905303337877
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding gastrointestinal disorders in at-risk infants
This study looks at how common gut problems are in at-risk infants, like those born early or who had trouble at birth, to see how these issues affect their growth and health in the first two years of life.
-
Gut health follow-along with Peachbiotic in adults
This single-arm study tests whether Peachbiotic taken daily for 12 weeks helps adults with gut symptoms feel better.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
-
Impact of a climate-resilient WASH package in Karamoja schools
This study tests a climate-resilient water, sanitation and hygiene package in severely water-insecure primary schools in Karamoja to see if it reduces diarrhea and respiratory infections and improves attendance, especially among girls.
-
Do home water filters improve health for people with private wells in rural Central Appalachia
This study tests whether providing point-of-use water filters to households using well or spring water in rural Central Appalachia can reduce acute gastrointestinal illness.
-
Home-based assessment and treatment to avoid hospital admission for nursing home residents
This study tests whether on-site care by municipal teams can safely reduce hospital visits for nursing home residents who become acutely ill or deteriorate after hours.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.